Letter to the FTC Regarding Life Line Screening’s Advertising of Its Cardiovascular Disease and Osteoporosis Screening Package

January 22, 2015

View the Letter and Enclosures as a PDF.

View the Press Release.

Public Citizen urges the Federal Trade Commission (FTC) to investigate the direct-to-consumer advertising and promotional activities of the cardiovascular disease screening company Life Line Screening. The company’s advertising materials make unsubstantiated claims about the medical benefits of its cardiovascular disease and osteoporosis screening package and omit information about the risks of adverse health-related outcomes and financial harms that may result from the screenings.

January 27, 2015, View the Initial FTC Response.